Chronicle Journal: Finance

Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
S&P Biotech SPDR (NY: XBI)
95.36 USD  +0.54 (+0.57%)
Official Closing Price  /  Updated: 7:59 PM EST, Dec 13, 2019  /  Add to My Watchlist      
View: Quote News
Fund Overview
S&P Biotech SPDR
Sector
Exchange Traded NY
Net Assets 5.15B
Inception Date
Related Funds
Quote
Price 95.36
Volume 4,165,300
Last Trade Dec 13, 7:59pm
Change (%)
+0.54 (0.57%)
Prev. Close 94.82
YTD %
+30.88%
Dividend Yield 0.24%
Performance
YTD
+22.50 (30.88%)
1 Month
+11.12 (13.20%)
3 Month
+12.94 (15.70%)
6 Month
+13.87 (17.02%)
1 Year
+17.49 (22.46%)
Chart
Charting
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
The Daily Biotech Pulse: Second Time's The Charm For Sarepta, Pfizer's Xeljanz Snags Third Approval, NewLink Genetics Rejects Competing Offer
The following is a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks that ... Read More
from Benzinga
Investors Moving Back Into Resurgent Biotech ETFs
After stumbling through much of 2019, biotechnology ETFs are finding their grooves in the fourth quarter. Since the start of the current quarter, the iShares Nasdaq Biotechnology ETF ( IBB B+ ) is... Read More
from ETFdb
Top News
More News
Best ETF Strategies For 2020
With expensive valuations and rising uncertainties, investors should stay invested but limit downside risk. Read More
from Blogs - TalkMarkets
There’s more upside for biotech even after 24% gains in two months
Seven biotech stocks to consider buying. Read More
from MarketWatch
The Daily Biotech Pulse: European Nod For Amgen, miRagen Overhauls Clinical Pipeline, Tonix Snags Patent Win
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting ... Read More
from Benzinga
The Daily Biotech Pulse: Correvio Faces FDA Panel Rejection, Iterum's Antibiotic Trial Narrowly Misses Primary Endpoint
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting ... Read More
from Benzinga
Why Biotech ETFs Are Surging To New Highs
We have seen very strong M&A activity in the biotech space of late and the trend is expected to continue as big pharmaceutical companies are trying to gain an edge in the increasingly competitive... Read More
from Blogs - TalkMarkets
The Daily Biotech Pulse: ASH Meeting Wraps, Fast Track Designation For Equillium, Pfizer To Buy $3M In ContraFect Shares
The following are top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks that hit 52-week ... Read More
from Benzinga
Investors Are Moving Back Into Resurgent Biotech ETFs
After stumbling through much of 2019, biotechnology ETFs are finding their grooves in the fourth quarter. Since the start of the current quarter, the iShares Nasdaq Biotechnology ETF (NasdaqGS: IBB) is... Read More
from ETF Trends
The Week Ahead In Biotech: ASH Presentations Pick Up Steam, Correvio Awaits Adcom Ruling
Biotech stocks went back and forth but managed to end the week with a gain. As usual, some stocks swung wildly in reaction to catalysts, ... Read More
from Benzinga
Stocks Are Set To Soar On Huge Employment Report Beat
Stocks are pointing to a higher opening on December 6 following better than expected jobs data. Read More
from Blogs - TalkMarkets
The Daily Biotech Pulse: Cassava Gains On Alzheimer's Presentation, Bristol-Myers Hikes Dividend
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks hitting ... Read More
from Benzinga
The Daily Biotech Pulse: Aurinia Rips Higher On Positive Readout, Sesen Bio On Track For Vicinium BLA Submission
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... Read More
from Benzinga
The Daily Biotech Pulse: Roche's Tecentriq Snags FDA Nod For Lung Cancer, Rapt Out-Licenses Cancer Drug
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting ... Read More
from Benzinga
3 Best Performing Biotech Funds So Far In 2019
Investors who wish to make the best of the biotechnology industry’s gains could consider investing in mutual funds focused on biotechnology companies. Read More
from Blogs - TalkMarkets
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

© Copyright 2015, Chronicle Journal, Thunder Bay, ON. Powered by BLOX Content Management System from TownNews.com. [Terms of Use | Privacy Policy]